Advanced Biomed Inc. Common Stock
ADVB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $9,697 | $15,148 | $78,400 | $73,000 |
| - Cash | $2,657 | $99 | $156 | $2,657 |
| + Debt | $56 | $43 | $187 | $1,910 |
| Enterprise Value | $7,096 | $15,092 | $78,431 | $72,253 |
| Revenue | $0 | $17 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | -$2 | -$2 | -$2 | -$3 |
| % Margin | – | -12.1% | – | – |
| EBITDA | -$11 | -$21 | -$685 | -$427 |
| % Margin | – | -120.1% | – | – |
| Net Income | -$13 | -$23 | -$1,384 | -$908 |
| % Margin | – | -132.2% | – | – |
| EPS Diluted | -0.001 | -0.001 | -0.069 | -0.045 |
| % Growth | 45.5% | 98.4% | -52% | – |
| Operating Cash Flow | -$20 | -$59 | -$103 | -$842 |
| Capital Expenditures | -$0 | -$1 | -$0 | $11 |
| Free Cash Flow | -$20 | -$59 | -$103 | -$831 |